References
- Orchard, J. A., Bolam, S. and Oscier, D. G. (1998). Association of myelodysplastic changes with purine analogues, British Journal of Haematology, 100, 677–679.
- Van Den Neste, E., Louviaux, I., Michaux, J. L., Delannoy, A., Michaux, L., Hagemeir, A., Scheiff, J. M., Bosly, A. and Ferrant, A. (1999). Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2′-deoxyadenosine, British Journal Haematology, 105, 268–270.
- Kroft, S. H., Tallman, M. S., Shaw, J. M., Thangavelu, M. and Peterson, L. C. (1997). Myelodysplasia following treatment of chronic lymphocytic leukaemia (CLL) with 2-chlorodeoxyadenosine (2-CdA), Leukemia, 11, 170.
- Frewin, R. J., Provan, D. and Smith, A. G. (1997). Myelodysplasia occurring after treatment for chronic lymphocytic leukaemia, Clinical and Laboratory Haematology, 19, 151–152.
- Kong, L. R., Huang, C. F., Hakimian, D., Variakojis, D., Klein, L., Kuzel, T. M., Gordon, L. I., Zanzig, C., Wollins, E. and Tallman, M. S. (1998). Longterm follow-up and late complications of 2-chlorodeoxy-adenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma, Cancer, 82, 957–964.
- Laurencet, F. M., Zulian, G. B., Cabrol, C. and Betticher, D. C. (1997). Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-deoxyadenosine) and involved field radiation therapy, Genetics and Cytogenetics, 99, 85–89.
- Robertson, L. E., Estey, E., Kantarjian, H., Koller, C., O'Brien, S., Brown, B. and Keating, M. (1994). Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukaemia, Leukemia, 8, 2047–2051.
- Psiachou-Leonard, E. and Bain, B. J. (1998). Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia, Clin Lab Haem, 20, 195–197.
- Schlaifer, D., Rigal-Huguet, F., Pris, J., Brousset, P., Delannoy, A. and Bosly, A. (1994). Secondary neoplasms in two patients treated with purine analogues, Nouvelle Revue Francaise, 36, 341.